BIS vs. RSPN
Compare and contrast key facts about ProShares UltraShort Nasdaq Biotechnology (BIS) and Invesco S&P 500® Equal Weight Industrials ETF (RSPN).
BIS and RSPN are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BIS is a passively managed fund by ProShares that tracks the performance of the NASDAQ Biotechnology Index (-200%). It was launched on Apr 7, 2010. RSPN is a passively managed fund by Invesco that tracks the performance of the S&P 500® Equal Weight Industrials Index. It was launched on Jan 11, 2006. Both BIS and RSPN are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BIS or RSPN.
Correlation
The correlation between BIS and RSPN is 0.82, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
BIS vs. RSPN - Performance Comparison
Loading data...
Key characteristics
BIS:
0.48
RSPN:
0.41
BIS:
1.02
RSPN:
0.81
BIS:
1.12
RSPN:
1.11
BIS:
0.21
RSPN:
0.44
BIS:
1.57
RSPN:
1.44
BIS:
13.56%
RSPN:
6.40%
BIS:
43.40%
RSPN:
20.14%
BIS:
-99.77%
RSPN:
-61.64%
BIS:
-99.66%
RSPN:
-8.00%
Returns By Period
In the year-to-date period, BIS achieves a 16.45% return, which is significantly higher than RSPN's 0.63% return. Over the past 10 years, BIS has underperformed RSPN with an annualized return of -15.92%, while RSPN has yielded a comparatively higher 10.98% annualized return.
BIS
16.45%
-8.13%
49.30%
18.66%
-8.38%
-15.92%
RSPN
0.63%
9.85%
-7.11%
7.86%
19.23%
10.98%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BIS vs. RSPN - Expense Ratio Comparison
BIS has a 0.95% expense ratio, which is higher than RSPN's 0.40% expense ratio.
Risk-Adjusted Performance
BIS vs. RSPN — Risk-Adjusted Performance Rank
BIS
RSPN
BIS vs. RSPN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Nasdaq Biotechnology (BIS) and Invesco S&P 500® Equal Weight Industrials ETF (RSPN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
BIS vs. RSPN - Dividend Comparison
BIS's dividend yield for the trailing twelve months is around 3.10%, more than RSPN's 0.98% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
BIS ProShares UltraShort Nasdaq Biotechnology | 3.10% | 3.73% | 1.75% | 0.00% | 0.00% | 0.44% | 2.10% | 0.37% |
RSPN Invesco S&P 500® Equal Weight Industrials ETF | 0.98% | 0.98% | 0.55% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
BIS vs. RSPN - Drawdown Comparison
The maximum BIS drawdown since its inception was -99.77%, which is greater than RSPN's maximum drawdown of -61.64%. Use the drawdown chart below to compare losses from any high point for BIS and RSPN. For additional features, visit the drawdowns tool.
Loading data...
Volatility
BIS vs. RSPN - Volatility Comparison
ProShares UltraShort Nasdaq Biotechnology (BIS) has a higher volatility of 20.00% compared to Invesco S&P 500® Equal Weight Industrials ETF (RSPN) at 6.64%. This indicates that BIS's price experiences larger fluctuations and is considered to be riskier than RSPN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...